Geron Corp (GERN)
4.07
+0.05
(+1.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Geron Price: 4.07 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 3.98 | 4.105 | 3.96 | 4.07 | 6.845M |
| Nov 21, 2024 | 4.04 | 4.05 | 3.96 | 4.02 | 6.807M |
| Nov 20, 2024 | 3.76 | 4.00 | 3.725 | 3.99 | 9.508M |
| Nov 19, 2024 | 3.73 | 3.80 | 3.64 | 3.79 | 11.49M |
| Nov 18, 2024 | 3.685 | 3.86 | 3.60 | 3.78 | 11.56M |
| Nov 15, 2024 | 3.73 | 3.78 | 3.63 | 3.66 | 10.52M |
| Nov 14, 2024 | 3.86 | 3.945 | 3.68 | 3.71 | 10.04M |
| Nov 13, 2024 | 3.97 | 4.05 | 3.815 | 3.87 | 11.96M |
| Nov 12, 2024 | 4.10 | 4.21 | 3.95 | 3.97 | 11.41M |
| Nov 11, 2024 | 4.19 | 4.255 | 4.09 | 4.12 | 8.362M |
| Nov 08, 2024 | 4.21 | 4.33 | 4.15 | 4.25 | 12.14M |
| Nov 07, 2024 | 4.50 | 4.50 | 4.15 | 4.29 | 38.43M |
| Nov 06, 2024 | 4.35 | 4.41 | 4.255 | 4.27 | 13.02M |
| Nov 05, 2024 | 4.30 | 4.32 | 4.12 | 4.22 | 6.029M |
| Nov 04, 2024 | 4.08 | 4.26 | 3.98 | 4.25 | 7.033M |
| Nov 01, 2024 | 4.12 | 4.31 | 4.01 | 4.11 | 8.093M |
| Oct 31, 2024 | 4.12 | 4.195 | 4.08 | 4.11 | 4.654M |
| Oct 30, 2024 | 4.22 | 4.29 | 4.13 | 4.15 | 3.851M |
| Oct 29, 2024 | 4.19 | 4.28 | 4.185 | 4.26 | 3.747M |
| Oct 28, 2024 | 4.10 | 4.25 | 4.08 | 4.22 | 7.940M |
| Oct 25, 2024 | 3.98 | 4.10 | 3.88 | 4.06 | 5.778M |
| Oct 24, 2024 | 4.08 | 4.115 | 3.97 | 4.00 | 5.134M |
| Oct 23, 2024 | 4.00 | 4.08 | 3.91 | 4.07 | 5.150M |
| Oct 22, 2024 | 3.91 | 4.04 | 3.874 | 4.01 | 9.209M |
| Oct 21, 2024 | 4.07 | 4.10 | 3.92 | 3.95 | 7.317M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8873
Minimum
Mar 18 2020
5.09
Maximum
Jun 11 2024
2.178
Average
1.88
Median
Oct 19 2020
Price Benchmarks
| Emergent BioSolutions Inc | 9.48 |
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.96 |
| iBio Inc | 2.64 |
| Theriva Biologics Inc | 1.28 |
Price Related Metrics
| PS Ratio | 86.80 |
| Price to Book Value | 8.418 |
| Earnings Yield | -7.86% |
| Market Cap | 2.460B |